Bibliographic Details
| Title: |
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. |
| Authors: |
Calabresi PA; Johns Hopkins Multiple Sclerosis Center, Baltimore, MD, USA. Calabresi@jhmi.edu, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, Hutchinson M, Kappos L, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Lublin FD, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA |
| Corporate Authors: |
AFFIRM and SENTINEL Investigators |
| Source: |
Neurology [Neurology] 2007 Oct 02; Vol. 69 (14), pp. 1391-403. Date of Electronic Publication: 2007 Aug 29. |
| Publication Type: |
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
